FORT COLLINS, Colo.--(BUSINESS WIRE)--VetDC, Inc., today announced that it is presenting data on VDC-1101 at the 2012 American College of Veterinary Internal Medicine Forum. VDC-1101 is a novel anti-proliferative agent that preferentially targets lymphoid cells and works by inhibiting cellular DNA synthesis, leading to the induction of apoptosis, or programmed cell death.
